Clinical Trials Browser

Withdrawn × Breast Neoplasms × Breast × Clear all

NCT06229392 2026-03-11

A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer

Phase 1 Withdrawn

Breast Neoplasms, Influenza, Human, Triple Negative Breast Neoplasms

NCT03804255 2026-03-02

Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT07439432 2026-02-27

Stereotactic Guided Biopsy and Cryoablation

Phase NA Withdrawn

Breast Neoplasms

NCT05014295 2026-02-24

Patient Recall of Cancer Screening and Diagnosis

Phase NA Withdrawn

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT06829199 2026-02-19

MK-5890-003

Phase 2 Withdrawn

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06585969 2026-02-12

DISCORDANT

Phase 3 Withdrawn

Breast Neoplasms

NCT05512260 2026-02-11

BESTa

Phase NA Withdrawn

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT06613516 2025-12-24

CaptAin

Phase 2 Withdrawn

Breast Neoplasms

NCT05957042 2025-12-10

Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).

Phase EARLY_PHASE1 Withdrawn

Breast Neoplasms

NCT07092475 2025-11-26

The Impact of Intraoperative Methadone on Postoperative Opioid Use

Phase 3 Withdrawn

Breast Neoplasms

NCT02825810 2025-11-18

Cervical Motor Control in Long-term Breast Cancer Survivors

Phase NA Withdrawn

Breast Neoplasms, Neck Pain

NCT05634954 2025-10-23

Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer

Phase 1 Withdrawn

Breast Neoplasms

NCT04794816 2025-10-14

What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care

Breast Neoplasms

NCT06884254 2025-10-14

EGC102

Phase 3 Withdrawn

Breast Neoplasms

NCT03974204 2025-09-26

Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis.

Phase NA Withdrawn

Breast Neoplasms, Meningeal Carcinomatosis

NCT06672224 2025-09-17

Indocyanine Green Fluoroscopy and SPY Angiography for the Assessment of Lymphatic Structure in Breast Cancer Patients at Risk for Breast Cancer-Related Lymphedema

Phase NA Withdrawn

Breast Cancer Lymphedema, Breast Neoplasms

NCT01827969 2025-09-16

USF

Phase NA Withdrawn

Breast Neoplasms

NCT00466830 2025-09-11

SDPM

Breast Neoplasms, Pain

NCT00210145 2025-09-04

ASE K SEIN

Breast Neoplasms

NCT04756765 2025-08-17

Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms

NCT05678205 2025-07-30

A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors

Phase 1/2 Withdrawn

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT06852560 2025-06-26

GEM

Phase NA Withdrawn

Breast Neoplasms, Atherosclerosis

NCT03941223 2025-06-25

Regional Anesthesia for Breast Surgery

Phase NA Withdrawn

Breast Neoplasms

NCT06494046 2025-06-04

Defining Musical Toxicity and Its Effect on Patient Well-being

BreastCNSGastrointestinalThoracic

Brain Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms

NCT01349088 2025-05-02

Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer

Phase 1/2 Withdrawn

Breast Neoplasms

NCT05940844 2025-04-09

Study of OB-002 in Patients With Refractory Metastatic Cancer

Phase 1 Withdrawn

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Neoplasm Metastasis, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT04889495 2025-03-19

A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer

BreastGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Kidney Neoplasms, Colorectal Neoplasms

NCT06341647 2025-01-24

Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201

Phase 1 Withdrawn

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT02883361 2024-12-05

MI for AIs

Phase 2/3 Withdrawn

Breast Neoplasms, Medication Adherence

NCT04160182 2024-11-26

Feasibility and Effectiveness of an Internet-based Intervention to Manage Fatigue in Breast Cancer Survivors

Phase NA Withdrawn

Breast Neoplasms, Fatigue

NCT04232319 2024-11-26

Feasibility and Effectiveness of a Sleep Hygiene Education Program for Sleep Issues in Breast Cancer Survivors

Phase NA Withdrawn

Sleep Hygiene, Breast Neoplasms

NCT05427344 2024-11-26

Effectiveness of Aquatic Exercise on Fatigue, Neuropathy and Quality of Life Among Cancer Patients

Phase NA Withdrawn

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT04985357 2024-11-25

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

BreastEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Anus Neoplasms, Appendiceal Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lip Neoplasms, Lung Neoplasms, Mesothelioma, Mouth Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Paranasal Sinus Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Ductal, Small Cell Lung Carcinoma

NCT04007549 2024-11-19

IBMC

Phase NA Withdrawn

Alcohol Drinking, Breast Neoplasms, Smoking Cessation

NCT04364672 2024-11-04

Molecular Neuroimaging to Assess the Link Between Neuroinflammation and Cognitive Impairment in Breast Cancer

Phase 1 Withdrawn

Breast Neoplasms

NCT05488444 2024-10-22

A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical Care

Phase 2 Withdrawn

Breast Neoplasms

NCT03238053 2024-10-16

Laser Treatment of Genito-urinary Syndrome in Women

Phase NA Withdrawn

BreastGenitourinaryGynecologic

Breast Neoplasms, Vaginitis, Endometrial Neoplasms, Urinary Bladder, Overactive

NCT01960803 2024-10-04

Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT)

Phase NA Withdrawn

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT06105008 2024-08-23

Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms

NCT04540471 2024-08-21

Music Therapy in Patients With Breast Cancer- a Randomized Controlled Trial

Phase NA Withdrawn

Anxiety Disorders, Breast Neoplasms, Fatigue

NCT05672342 2024-08-09

Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT04880369 2024-08-07

DAGMAR

Phase NA Withdrawn

Breast Neoplasms

NCT05039931 2024-07-18

A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1 Withdrawn

Breast Neoplasms, Lung Neoplasms

NCT02407613 2024-05-21

Efficacy of MR-HIFU Ablation of Breast Cancer

Phase NA Withdrawn

Breast Neoplasms

NCT06057636 2024-05-10

Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study

Phase NA Withdrawn

Cancer Pain, Agnosia, Breast Neoplasms, Neoplasm Metastasis, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05073172 2024-05-06

StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients

Phase NA Withdrawn

Breast Neoplasms, Radiodermatitis

NCT05212701 2024-04-30

To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms, Fatigue

NCT06137651 2024-04-01

Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis

Phase 1 Withdrawn

Brain Neoplasms, Breast Neoplasms, Meningeal Carcinomatosis

NCT03841747 2024-03-12

PELICAN

Phase 2 Withdrawn

Breast Neoplasms, Neoplasm Metastasis

NCT04102436 2024-03-12

Non-Viral TCR Gene Therapy

Phase 2 Withdrawn

BreastGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Urogenital Neoplasms